← Every company

Castle Biosciences Inc SEC Filings

What Castle Biosciences Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.

CSTL overview →
Filings on file
100
since Jun 26, 2019
Warning signs
1
latest Mar 5, 2020
Last results
Jul 30, 2026
8-K item 2.02
Industry
Services-Medical Laboratories
SIC 8071

Newest first

Each label is a form type or an 8-K item as filed; each row links to the filing.

FiledWhat it reportsDocument
Mar 27, 2024
Executive or director changeMaterial agreement
8-K
Read ↗
Nov 9, 2023
Executive or director change
8-K
Read ↗
Jan 20, 2023
Executive or director change
8-K
Read ↗
Dec 28, 2022
Executive or director change
8-K
Read ↗
Dec 15, 2022
Executive or director change
8-K
Read ↗
Jan 5, 2022
Executive or director change
8-K
Read ↗
Jul 16, 2021
Executive or director change
8-K
Read ↗
Apr 9, 2021
Executive or director change
8-K
Read ↗
Aug 20, 2020
Executive or director change
8-K
Read ↗
Jun 2, 2020
Executive or director change
8-K
Read ↗
May 28, 2020
Executive or director change
8-K
Read ↗
Apr 1, 2020
Executive or director change
8-K
Read ↗
Dec 19, 2019
Executive or director changeMaterial agreement
8-K
Read ↗

Source: Castle Biosciences Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.

More on CSTL

Related datasets